A single blind comparison of dihydroergotoxine mesilate and clonidine for treatment of hypertensive emergencies

E. Guffanti; A. Vaccarella; M. Meregalli; G. Fiorella; S. M. Chierichetti; C. Mazzola

A single blind comparison of dihydroergotoxine mesilate and clonidine for treatment of hypertensive emergencies

E. Guffanti, A. Vaccarella, M. Meregalli, G. Fiorella, S. M. Chierichetti, C. Mazzola

Istituto Nazionale di Riposo e Cura per Anziani V.E. II

Research output: Contribution to journal › Article › peer-review

Abstract

The effectiveness and safety of dihydroergotoxine mesylate (DHT) and clonidine (CLO) as acute antihypertensive treatments were studied in a single-blind randomized controlled study of 28 patients hospitalized after abrupt increases in mean blood pressure (MAP) to more than 150 mmHg, with concomitant symptoms related to hypertensive status (16 patients). Intravenous infusion of 1.5 mg DHT significantly reduced both systolic (SBP) and diastolic (DBP) blood pressure from 227 ± 2/128 ± 2 mmHg to 160 ± 4/94 ± 2 mmHg by 1 hour after the onset of infusion (p

Original language	English
Pages (from-to)	506-509
Number of pages	4
Journal	International Journal of Clinical Pharmacology Therapy and Toxicology
Volume	23
Issue number	9
Publication status	Published - 1985

ASJC Scopus subject areas

Toxicology
Pharmacology (medical)

Fingerprint Dive into the research topics of 'A single blind comparison of dihydroergotoxine mesilate and clonidine for treatment of hypertensive emergencies'. Together they form a unique fingerprint.

Cite this

A single blind comparison of dihydroergotoxine mesilate and clonidine for treatment of hypertensive emergencies. / Guffanti, E.; Vaccarella, A.; Meregalli, M.; Fiorella, G.; Chierichetti, S. M.; Mazzola, C.

In: International Journal of Clinical Pharmacology Therapy and Toxicology, Vol. 23, No. 9, 1985, p. 506-509.

Research output: Contribution to journal › Article › peer-review

@article{e5b6ea4dd30f492da83bc3d75a24c850,

title = "A single blind comparison of dihydroergotoxine mesilate and clonidine for treatment of hypertensive emergencies",

abstract = "The effectiveness and safety of dihydroergotoxine mesylate (DHT) and clonidine (CLO) as acute antihypertensive treatments were studied in a single-blind randomized controlled study of 28 patients hospitalized after abrupt increases in mean blood pressure (MAP) to more than 150 mmHg, with concomitant symptoms related to hypertensive status (16 patients). Intravenous infusion of 1.5 mg DHT significantly reduced both systolic (SBP) and diastolic (DBP) blood pressure from 227 ± 2/128 ± 2 mmHg to 160 ± 4/94 ± 2 mmHg by 1 hour after the onset of infusion (p",

author = "E. Guffanti and A. Vaccarella and M. Meregalli and G. Fiorella and Chierichetti, {S. M.} and C. Mazzola",

year = "1985",

language = "English",

volume = "23",

pages = "506--509",

journal = "International Journal of Clinical Pharmacology and Therapeutics",

issn = "0174-4879",

publisher = "Dustri-Verlag Dr. Karl Feistle",

number = "9",

}

TY - JOUR

T1 - A single blind comparison of dihydroergotoxine mesilate and clonidine for treatment of hypertensive emergencies

AU - Guffanti, E.

AU - Vaccarella, A.

AU - Meregalli, M.

AU - Fiorella, G.

AU - Chierichetti, S. M.

AU - Mazzola, C.

PY - 1985

Y1 - 1985

N2 - The effectiveness and safety of dihydroergotoxine mesylate (DHT) and clonidine (CLO) as acute antihypertensive treatments were studied in a single-blind randomized controlled study of 28 patients hospitalized after abrupt increases in mean blood pressure (MAP) to more than 150 mmHg, with concomitant symptoms related to hypertensive status (16 patients). Intravenous infusion of 1.5 mg DHT significantly reduced both systolic (SBP) and diastolic (DBP) blood pressure from 227 ± 2/128 ± 2 mmHg to 160 ± 4/94 ± 2 mmHg by 1 hour after the onset of infusion (p

AB - The effectiveness and safety of dihydroergotoxine mesylate (DHT) and clonidine (CLO) as acute antihypertensive treatments were studied in a single-blind randomized controlled study of 28 patients hospitalized after abrupt increases in mean blood pressure (MAP) to more than 150 mmHg, with concomitant symptoms related to hypertensive status (16 patients). Intravenous infusion of 1.5 mg DHT significantly reduced both systolic (SBP) and diastolic (DBP) blood pressure from 227 ± 2/128 ± 2 mmHg to 160 ± 4/94 ± 2 mmHg by 1 hour after the onset of infusion (p

UR - http://www.scopus.com/inward/record.url?scp=0021984658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021984658&partnerID=8YFLogxK

M3 - Article

C2 - 3902677

AN - SCOPUS:0021984658

VL - 23

SP - 506

EP - 509

JO - International Journal of Clinical Pharmacology and Therapeutics

JF - International Journal of Clinical Pharmacology and Therapeutics

SN - 0174-4879

IS - 9

ER -

A single blind comparison of dihydroergotoxine mesilate and clonidine for treatment of hypertensive emergencies

Abstract

ASJC Scopus subject areas

Other files and links

Cite this